Literature DB >> 17411414

Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.

Don C Des Jarlais1, Naomi Braine, Huso Yi, Charles Turner.   

Abstract

This study assessed relationships between residual risk behavior (risk behavior among persons participating in effective HIV prevention programs) and HIV infection. Structured interviews and HIV tests were obtained from participants in six large U.S. syringe exchange programs. Program characteristics were obtained through interviews with the directors. Findings indicated that injection risk behaviors varied significantly across the six programs--from 10% to 27% of the participants at each program reported receptive sharing of needles and syringes in the 30 days prior to the interview. HIV prevalence ranged from 2.5% to 22.2% across the six programs. HIV prevalence among new injectors was strongly related to HIV prevalence among long-term injectors across the programs (r = .869). There was a consistent pattern of negative relationships between injection risk behaviors and HIV infection across the six programs (higher rates of risk behavior at a program associated with lower HIV infection). As a result, appropriate evaluation of HIV prevention programs may require not only information on continuing risk behavior and HIV infection among program participants but also historical information on the epidemiology of HIV in the local community.

Entities:  

Mesh:

Year:  2007        PMID: 17411414     DOI: 10.1521/aeap.2007.19.2.111

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  13 in total

1.  Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes.

Authors:  Michael Kidorf; Van L King; Neeraj Gandotra; Ken Kolodner; Robert K Brooner
Journal:  Drug Alcohol Depend       Date:  2011-12-31       Impact factor: 4.492

2.  Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego.

Authors:  Fátima Muñoz; José Luis Burgos; Jazmine Cuevas-Mota; Eyasu Teshale; Richard S Garfein
Journal:  AIDS Behav       Date:  2015-01

3.  The perceived consequences of safer injection: an exploration of qualitative findings and gender differences.

Authors:  Karla D Wagner; Stephen E Lankenau; Lawrence A Palinkas; Jean L Richardson; Chih-Ping Chou; Jennifer B Unger
Journal:  Psychol Health Med       Date:  2010-10       Impact factor: 2.423

4.  Benefits of concurrent syringe exchange and substance abuse treatment participation.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Jessica Pierce; Ken Kolodner; Robert K Brooner
Journal:  J Subst Abuse Treat       Date:  2011-01-20

Review 5.  Cognitive behavioral theories used to explain injection risk behavior among injection drug users: a review and suggestions for the integration of cognitive and environmental models.

Authors:  Karla Dawn Wagner; Jennifer B Unger; Ricky N Bluthenthal; Valentina A Andreeva; Mary Ann Pentz
Journal:  Health Educ Behav       Date:  2010-08

6.  The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA.

Authors:  Carl A Latkin; Deborah Donnell; David Metzger; Susan Sherman; Apinun Aramrattna; Annet Davis-Vogel; Vu Minh Quan; Sharavi Gandham; Tasanai Vongchak; Tom Perdue; David D Celentano
Journal:  Soc Sci Med       Date:  2008-12-13       Impact factor: 4.634

7.  Longitudinal analysis of the relationship between perceived norms and sharing injection paraphernalia.

Authors:  Melissa A Davey-Rothwell; Carl A Latkin; Karin E Tobin
Journal:  AIDS Behav       Date:  2009-01-16

8.  Predictors of sharing injection equipment by HIV-seropositive injection drug users.

Authors:  Carl A Latkin; Amy S Buchanan; Lisa R Metsch; Kelly Knight; Mary H Latka; Yuko Mizuno; Amy R Knowlton
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

9.  Psychiatric distress, risk behavior, and treatment enrollment among syringe exchange participants.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Christopher Burke; Ken Kolodner; Robert K Brooner
Journal:  Addict Behav       Date:  2010-01-04       Impact factor: 3.913

10.  Who purchases nonprescription syringes? Characterizing customers of the Expanded Syringe Access Program (ESAP).

Authors:  Haven B Battles; Kirsten A Rowe; Christina Ortega-Peluso; Susan J Klein; James M Tesoriero
Journal:  J Urban Health       Date:  2009-11       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.